Latest Amyloid precursor protein Stories
HONOLULU, July 14 /PRNewswire/ -- EnVivo Pharmaceuticals today announced at the Alzheimer's Association 2010 International Conference on Alzheimer's Disease (ICAD) results from its proprietary gamma-secretase modulator (GSM) pre-clinical study.
- When Combined with a Known Alzheimer's Gene, Your Alzheimer's Risk may be Doubled - HONOLULU, July 12 /PRNewswire-USNewswire/ -- A gene known as FTO, which appears to be correlated with obesity in humans, may also increase risk of Alzheimer's disease and dementia, according to new research presented today at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 (AAICAD 2010) in Honolulu, HI.
According to a study published on Sunday, a gene linked to increased life span through calorie restriction also appears to play a critical role in boosting memory and brain power.
NEW YORK, July 8 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE: PFE) will present new data on its investigational compounds targeting various aspects of Alzheimer's disease (AD), a complex degenerative brain disorder.
WASHINGTON, July 7 /PRNewswire/ -- A new clinical trial shows that drinking apple juice significantly improved mood and behavior among a group of patients diagnosed with moderate-to-severe Alzheimer's disease (AD).
Scientists discovered characteristic amyloid plaques in retinas from Alzheimer's disease patients and used a noninvasive optical imaging technique to detect retinal plaques in live laboratory mice.
A trial of a novel radioactive compound readily and safely distinguished the brains of Alzheimer's disease patients from healthy volunteers on brain scans and opens the doors to making such imaging available beyond facilities that can manufacture their own radioactive compounds.
The first trial of a new model for testing Alzheimer's treatments has reassured researchers that a promising class of drugs does not exacerbate the disease if treatment is interrupted.
Researchers have discovered how mutations in the presenilin 1 gene cause early-onset Alzheimer's disease (AD).
Researchers at the University of Illinois have identified a potential drug target for the treatment of Alzheimerâ€™s disease: a receptor that is embedded in the membrane of neurons and other cells.
- The act of sweetening by admixture of some saccharine substance.